litlas
ログインアカウント作成

Leo I. Gordon

1979–2025 年に発表

別表記
Leo I Gordon
145
論文数
32,631
被引用数
89
h 指数
140
i10 指数

被引用数

Leo I. Gordon の年別被引用数1979 年: 被引用 1 件1981 年: 被引用 6 件1982 年: 被引用 5 件1983 年: 被引用 1 件1984 年: 被引用 1 件1985 年: 被引用 14 件1986 年: 被引用 14 件1987 年: 被引用 10 件1988 年: 被引用 5 件1989 年: 被引用 7 件1990 年: 被引用 9 件1991 年: 被引用 13 件1992 年: 被引用 12 件1993 年: 被引用 18 件1994 年: 被引用 19 件1995 年: 被引用 20 件1996 年: 被引用 17 件1997 年: 被引用 21 件1998 年: 被引用 18 件1999 年: 被引用 26 件2000 年: 被引用 46 件2001 年: 被引用 68 件2002 年: 被引用 89 件2003 年: 被引用 85 件2004 年: 被引用 94 件2005 年: 被引用 99 件2006 年: 被引用 77 件2007 年: 被引用 107 件2008 年: 被引用 109 件2009 年: 被引用 162 件2010 年: 被引用 246 件2011 年: 被引用 302 件2012 年: 被引用 332 件2013 年: 被引用 448 件2014 年: 被引用 454 件2015 年: 被引用 534 件2016 年: 被引用 385 件2017 年: 被引用 316 件2018 年: 被引用 247 件2019 年: 被引用 718 件2020 年: 被引用 728 件2021 年: 被引用 795 件2022 年: 被引用 797 件2023 年: 被引用 657 件2024 年: 被引用 1,101 件2025 年: 被引用 516 件2026 年: 被引用 9 件1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,097 件、この内訳の 27.5%イギリス: 引用元論文 1,196 件、この内訳の 8%中国: 引用元論文 1,088 件、この内訳の 7.3%ドイツ: 引用元論文 1,010 件、この内訳の 6.8%フランス: 引用元論文 720 件、この内訳の 4.8%イタリア: 引用元論文 658 件、この内訳の 4.4%カナダ: 引用元論文 584 件、この内訳の 3.9%スペイン: 引用元論文 559 件、この内訳の 3.8%スイス: 引用元論文 439 件、この内訳の 2.9%オーストラリア: 引用元論文 422 件、この内訳の 2.8%オランダ: 引用元論文 348 件、この内訳の 2.3%日本: 引用元論文 323 件、この内訳の 2.2%
0%27.5%その他 23.3%

機関

分野

  • Medicine58%
  • Biochemistry, Genetics and Molecular Biology31.3%
  • Immunology and Microbiology4.6%
  • Agricultural and Biological Sciences1.4%
  • Chemistry1.1%
  • Computer Science0.7%
  • その他2.9%

トピック

  • Lymphoma Diagnosis and Treatment8.7%
  • CAR-T cell therapy research7.8%
  • Chronic Lymphocytic Leukemia Research2.6%
  • Genomics and Phylogenetic Studies2.6%
  • Viral-associated cancers and disorders2.2%
  • Immune Cell Function and Interaction2.1%
  • その他74%

共著者

全論文

検索で開く
  1. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

    著者: Jeremy S Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Tina Albertson, Jacob Garcia, Ana Kostić, Mary Mallaney, K. OGASAWARA, Kathryn J. Newhall, Yeonhee Kim, D. Li, Tanya Siddiqi - The Lancet 2020 被引用: 2,331

  2. Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma

    著者: Frederick L. Locke, David B. Miklos, Caron A. Jacobson, Miguel‐Angel Perales, Marie José Kersten, Olalekan O. Oluwole, Armin Ghobadi, Aaron P. Rapoport, Joseph P. McGuirk, John M. Pagel, Javier Muñoz, Umar Farooq, Tom van Meerten, Patrick M. Reagan, Anna Sureda, Ian W. Flinn, Peter Vandenberghe, Kevin Song, Michael Dickinson, Monique C. Minnema, Peter A. Riedell, Lori A. Leslie, Sridhar Chaganti, Yin Yang, Simone Filosto, Jina Shah, Marco Schupp, Christina To, Paul Cheng, Leo I. Gordon, Jason R. Westin - New England Journal of Medicine 2021 被引用: 1,520

  3. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

    著者: Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Andrea B. Moffitt, Cassandra Love, Alexander Waldrop, Sirpa Leppä, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg, Peter Nørgaard, Mette Ølgod Pedersen, Anne Ortved Gang, Estrid Høgdall, Tayla B. Heavican, Waseem Lone, Javeed Iqbal, Qiu Qin, Guojie Li, So Young Kim, Jane Healy, Kristy L. Richards, Yuri Fedoriw, Leon Bernal‐Mizrachi, Jean L. Koff, Ashley D. Staton, Christopher R. Flowers, Ora Paltiel, Neta Goldschmidt, Maria Calaminici, Andrew Clear, John G. Gribben, Evelyn Nguyen, Magdalena Czader, Sarah L. Ondrejka, Angela M. B. Collie, Eric D. Hsi, Eric Tse, Rex Au-Yeung, Yok‐Lam Kwong, Gopesh Srivastava, William W.L. Choi, Andrew M. Evens, Monika Pilichowska, Manju Sengar, Nishitha Reddy, Shaoying Li, Amy Chadburn, Leo I. Gordon, Elaine S. Jaffe, Shawn Levy, Rachel E. Rempel, Tiffany J. Tzeng, Lanie E. Happ, Tushar Dave, Deepthi Rajagopalan, Jyotishka Datta, David B. Dunson, Sandeep S. Davé - Cell 2017 被引用: 1,146

  4. Lisocabtagene maraleucel as second-line therapy in adults with relapsed or refractory large B-cell lymphoma who were not intended for haematopoietic stem cell transplantation (PILOT): an open-label, phase 2 study

    著者: Alison R. Sehgal, Daanish Hoda, Peter A. Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard Hildebrandt, John E. Godwin, Patrick M. Reagan, Nina D. Wagner‐Johnston, James Essell, Rajneesh Nath, Scott R. Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K. Gupta, Ronald L. Dubowy, Aleco D’Andrea, Lei Wang, K. OGASAWARA, Jerill Thorpe, Leo I. Gordon - The Lancet Oncology 2022 被引用: 234

  5. Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001

    著者: Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Christine Dehner, Yeonhee Kim, K. OGASAWARA, Ana Kostić, Tanya Siddiqi - Blood 2023 被引用: 171

  6. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

    著者: Zheng Zhou, Laurie H. Sehn, Alfred Rademaker, Leo I. Gordon, Ann S. LaCasce, Allison Crosby‐Thompson, Ann Vanderplas, Andrew D. Zelenetz, Gregory A. Abel, Maria Alma Rodriguez, Auayporn Nademanee, Mark Kaminski, Myron S. Czuczman, Michael Millenson, Joyce C. Niland, Randy D. Gascoyne, Joseph M. Connors, Jonathan W. Friedberg, Jane N. Winter - Blood 2013 被引用: 953

  7. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

    著者: Bruce D. Cheson, Stephen M. Ansell, Larry Schwartz, Leo I. Gordon, Ranjana H. Advani, Heather A. Jacene, Axel Hoos, Sally F. Barrington, Philippe Armand - Blood 2016 被引用: 506

  8. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

    著者: Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson, Ranjana H. Advani, B. Andreadis, Nancy L. Bartlett, Lihua E. Budde, Paolo F. Caimi, Julie Chang, Beth Christian, Sven deVos, Bhagirathbhai Dholaria, Luis Fayad, Thomas M. Habermann, Muhammad Saad Hamid, Francisco J. Hernandez‐Ilizaliturri, Boyu Hu, Mark Kaminski, Yasmin Karimi, Chris R. Kelsey, Rebecca L. King, Susan Krivacic, Ann S. LaCasce, Megan S. Lim, Marcus Messmer, Mayur Narkhede, Rachel Rabinovitch, Praveen Ramakrishnan, Erin Reid, Kenneth B. Roberts, Hayder Saeed, Stephen D. Smith, Jakub Svoboda, Lode J. Swinnen, Joseph M. Tuscano, Julie M. Vose, Mary A. Dwyer, Hema Sundar - Journal of the National Comprehensive Cancer Network 2023 被引用: 117

  9. Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study

    著者: Michael Wang, Tanya Siddiqi, Leo I. Gordon, Manali Kamdar, Matthew A. Lunning, Alexandre V. Hirayama, Jeremy S. Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Charalambos Andreadis, Scott R. Solomon, Ana Kostić, Christine Dehner, Ricardo Espinola, Lily Peng, K. OGASAWARA, Amy M. Chattin, Laurie Eliason, M. Lia Palomba - Journal of Clinical Oncology 2023 被引用: 94

  10. The genetic landscape of mutations in Burkitt lymphoma

    著者: Cassandra Love, Zhen Sun, Dereje D. Jima, Guojie Li, Jenny Zhang, Rodney R. Miles, Kristy L. Richards, Cherie H. Dunphy, William W.L. Choi, Gopesh Srivastava, Patricia Lugar, David A. Rizzieri, Anand S. Lagoo, Leon Bernal‐Mizrachi, Karen P. Mann, Christopher R. Flowers, Kikkeri N. Naresh, Andrew M. Evens, Amy Chadburn, Leo I. Gordon, Magdalena Czader, Javed Gill, Eric D. Hsi, Adrienne Greenough, Andrea B. Moffitt, Matthew McKinney, Anjishnu Banerjee, Vladimir Grubor, Shawn Levy, David B. Dunson, Sandeep S. Davé - Nature Genetics 2012 被引用: 597

  11. Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma

    著者: Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas, Myron S. Czuczman, Christos Emmanouilides, Robin Joyce, Brad Pohlman, Nancy L. Bartlett, Gregory A. Wiseman, Norman M. Padre, Antonio J Grillo-López, Pratik S. Multani, Christine A. White - Journal of Clinical Oncology 2002 被引用: 1,166

  12. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study

    著者: Narendranath Epperla, Lei Feng, Nirav N. Shah, Lindsey Fitzgerald, Harsh Shah, Deborah M. Stephens, Catherine J. Lee, Thomas Ollila, Geoffrey Shouse, Alexey V. Danilov, Kevin A. David, Pallawi Torka, Hamza Hashmi, Brian Hess, Stefan K. Barta, Jason T. Romancik, Jonathon B. Cohen, Kaitlin Annunzio, Adam S. Kittai, John Reneau, Joanna Zurko, Imran Nizamuddin, Jane N. Winter, Leo I. Gordon, Shuo Ma, Romil Patel, Loretta J. Nastoupil, Sairah Ahmed, Reem Karmali - Journal of Hematology & Oncology 2023 被引用: 53

  13. In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma

    著者: Matthew J. Frank, Patrick M. Reagan, Nancy L. Bartlett, Leo I. Gordon, Jonathan W. Friedberg, Debra K. Czerwinski, Steven Long, Richard T. Hoppe, Robert S. Janssen, Albert F. Candia, Robert L. Coffman, Ronald Levy - Cancer Discovery 2018 被引用: 188

  14. Peri–CAR-T practice patterns and survival predictors for all CAR-T patients and post–CAR-T failure in aggressive B-NHL

    著者: Joanna Zurko, Imran Nizamuddin, Narendranath Epperla, Kevin A. David, Jonathon B. Cohen, Tamara K. Moyo, Thomas Ollila, Brian Hess, Ishan Roy, Robert Ferdman, Jieqi Liu, Sayan Mullick Chowdhury, Jason T. Romancik, Rahul S. Bhansali, Elyse I. Harris, McKenzie Sorrell, Rebecca Masel, Adam S. Kittai, Nathan Denlinger, Audrey M. Sigmund, Lindsey Fitzgerald, Carlos Galvez, Shuo Ma, Jane N. Winter, Barbara Pro, Leo I. Gordon, Alexey V. Danilov, Deborah M. Stephens, Nirav N. Shah, Vaishalee P. Kenkre, Stefan K. Barta, Pallawi Torka, Geoffrey Shouse, Reem Karmali - Blood Advances 2022 被引用: 50

  15. Ensembl 2014

    著者: Paul Flicek, M Ridwan Amode, Daniel Barrell, Kathryn Beal, Konstantinos Billis, Simon Brent, Denise Carvalho‐Silva, Peter Clapham, Guy Coates, Stephen Fitzgerald, Laurent Gil, Carlos García Girón, Leo I. Gordon, Thibaut Hourlier, Sarah Hunt, Nathan Johnson, Thomas Juettemann, Andreas Kähäri, Stephen Keenan, Eugene Kulesha, Fergal J. Martin, Thomas Maurel, William McLaren, Daniel N. Murphy, Rishi Nag, Bert Overduin, Miguel Pignatelli, Bethan Pritchard, Emily Pritchard, Harpreet Singh Riat, Magali Ruffier, Dan Sheppard, Kieron Taylor, Anja Thormann, Stephen J. Trevanion, Alessandro Vullo, Steven P. Wilder, Mark Wilson, Amonida Zadissa, Bronwen Aken, Ewan Birney, Fiona Cunningham, Jennifer Harrow, Javier Herrero, Tim Hubbard, Rhoda Kinsella, Matthieu Muffato, Anne Parker, Giulietta Spudich, Andy Yates, Daniel R. Zerbino, Stephen M. J. Searle - Nucleic Acids Research, Nucleic Acids Res. 2013 被引用: 1,272

  16. Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma

    著者: Andrew M. Evens, Ranjana H. Advani, Irene Helenowski, Michelle A. Fanale, Sonali M. Smith, Borko Jovanovic, Gregory Bociek, Andreas K. Klein, Jane N. Winter, Leo I. Gordon, Paul A. Hamlin - Journal of Clinical Oncology 2018 被引用: 159

  17. Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis

    著者: Jonathan S. Rink, Adam Yuh Lin, Kaylin M. McMahon, Andrea E. Calvert, Shuo Yang, Tim Taxter, Jonathan Moreira, Amy Chadburn, Amir Behdad, Reem Karmali, C. Shad Thaxton, Leo I. Gordon - Journal of Biological Chemistry 2020 被引用: 51

  18. Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma

    著者: Locke J. Bryan, Carla Casulo, Pamela B. Allen, Scott E. Smith, Hatice Savas, Gary Dillehay, Reem Karmali, Barbara Pro, Kaitlyn Kane, Latifa A. Bazzi, Joan S. Chmiel, Brett Alan Palmer, Jayesh Mehta, Leo I. Gordon, Jane N. Winter - JAMA Oncology 2023 被引用: 65

  19. Two-Year Follow-up of Transcend NHL 001, a Multicenter Phase 1 Study of Lisocabtagene Maraleucel (liso-cel) in Relapsed or Refractory (R/R) Large B-Cell Lymphomas (LBCL)

    著者: Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison R. Sehgal, Scott R. Solomon, Nilanjan Ghosh, Ana Kostić, Yeonhee Kim, K. OGASAWARA, Christine Dehner, Tanya Siddiqi - Blood 2021 被引用: 57

  20. Ensembl 2013

    著者: Paul Flicek, Ikhlak Ahmed, M Ridwan Amode, Daniel Barrell, Kathryn Beal, Simon Brent, Denise Carvalho‐Silva, Peter Clapham, Guy Coates, Susan Fairley, Stephen Fitzgerald, Laurent Gil, Carlos García Girón, Leo I. Gordon, Thibaut Hourlier, Sarah Hunt, Thomas Juettemann, Andreas Kähäri, Stephen Keenan, Monika Komorowska, Eugene Kulesha, Ian Longden, Thomas Maurel, William McLaren, Matthieu Muffato, Rishi Nag, Bert Overduin, Miguel Pignatelli, Bethan Pritchard, Emily Pritchard, Harpreet Singh Riat, Graham R. S. Ritchie, Magali Ruffier, Michael Schuster, Dan Sheppard, Daniel Sobral, Kieron Taylor, Anja Thormann, Stephen J. Trevanion, Simon White, Steven P. Wilder, Bronwen Aken, Ewan Birney, Fiona Cunningham, Ian Dunham, Jennifer Harrow, Javier Herrero, Tim Hubbard, Nathan Johnson, Rhoda Kinsella, Anne Parker, Giulietta Spudich, Andy Yates, Amonida Zadissa, Stephen M. J. Searle - Nucleic Acids Research, Nucleic Acids Res. 2012 被引用: 897

  21. NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021

    著者: Andrew D. Zelenetz, Leo I. Gordon, Julie Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, Lihua E. Budde, Paolo F. Caimi, Sven de Vos, Bhagirathbhai Dholaria, Bita Fakhri, Luis Fayad, Martha Glenn, Thomas M. Habermann, Francisco J. Hernandez‐Ilizaliturri, Eric D. Hsi, Boyu Hu, Mark Kaminski, Chris R. Kelsey, Nadia Khan, Susan Krivacic, Ann S. LaCasce, Megan S. Lim, Mayur Narkhede, Rachel Rabinovitch, Praveen Ramakrishnan, Erin Reid, Kenneth B. Roberts, Hayder Saeed, Stephen D. Smith, Jakub Svoboda, Lode J. Swinnen, Joseph M. Tuscano, Julie M. Vose, Mary A. Dwyer, Hema Sundar - Journal of the National Comprehensive Cancer Network 2021 被引用: 170

  22. Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma

    著者: Jia Ruan, Jasmine M. Zain, Brett Alan Palmer, Borko Jovanovic, Xinlei Mi, Alok Swaroop, Jane N. Winter, Leo I. Gordon, Reem Karmali, Jonathan Moreira, Adam M. Petrich, Barbara Pro - Blood Advances 2023 被引用: 34

  23. Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis

    著者: SA Weitzman, Leo I. Gordon - Blood 1990 被引用: 748

  24. Ensembl 2017

    著者: Bronwen Aken, Premanand Achuthan, Wasiu Akanni, M Ridwan Amode, Friederike Bernsdorff, Jyothish Bhai, Konstantinos Billis, Denise Carvalho‐Silva, Carla Cummins, Peter Clapham, Laurent Gil, Carlos García Girón, Leo I. Gordon, Thibaut Hourlier, Sarah Hunt, Sophie H. Janacek, Thomas Juettemann, Stephen Keenan, Matthew R. Laird, Ilias Lavidas, Thomas Maurel, William McLaren, Benjamin Moore, Daniel N. Murphy, Rishi Nag, Victoria Newman, Michael Nuhn, Chuang Kee Ong, Anne Parker, Mateus Patrício, Harpreet Singh Riat, Dan Sheppard, Helen Sparrow, Kieron Taylor, Anja Thormann, Alessandro Vullo, Brandon Walts, Steven P. Wilder, Amonida Zadissa, Myrto Kostadima, Fergal J. Martin, Matthieu Muffato, Emily Perry, Magali Ruffier, D. Staines, Stephen J. Trevanion, Fiona Cunningham, Andrew Yates, Daniel R. Zerbino, Paul Flicek - Nucleic Acids Research, Nucleic Acids Res. 2016 被引用: 551